Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database

Drug–drug interactions (DDIs) between antihypertensive drugs and non‐steroidal anti‐inflammatory drugs (NSAIDs) can lead to adverse drug reactions (ADRs). Guidelines are available to help prescribers deal with these drug associations, but their implementation is not well evaluated. The aims of this...

Full description

Saved in:
Bibliographic Details
Published inFundamental & clinical pharmacology Vol. 28; no. 2; pp. 230 - 235
Main Authors Fournier, Jean-Pascal, Sommet, Agnès, Durrieu, Geneviève, Poutrain, Jean-Christophe, Lapeyre-Mestre, Maryse, Montastruc, Jean-Louis
Format Journal Article
LanguageEnglish
Published Oxford Blackwell Publishing Ltd 01.04.2014
Blackwell
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Drug–drug interactions (DDIs) between antihypertensive drugs and non‐steroidal anti‐inflammatory drugs (NSAIDs) can lead to adverse drug reactions (ADRs). Guidelines are available to help prescribers deal with these drug associations, but their implementation is not well evaluated. The aims of this study were to assess the prevalence of NSAIDs exposure in patients treated with antihypertensive drugs, using the French Pharmacovigilance database, and explore the ADRs related to DDIs between antihypertensive drugs and NSAIDs. Over the 11, 442 notifications of ADRs recorded in this database in patients treated with oral antihypertensive drugs between 2008 and 2010, 517 (4.5 and 95% CI: 4.1–4.9) also included exposure to NSAIDs. These subjects were more frequently women, took more drugs in general, and were younger and less frequently treated with antiplatelet drugs. In 24.2% of them (125 patients), a DDI between NSAIDs and antihypertensive drugs was potentially the cause of the reported ADR. Acute renal failure caused by DDIs between NSAIDs and angiotensin‐converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), or diuretics was the most frequently reported ADR (20.7%). Finally, in the French Pharmacovigilance database, around one‐fourth of associations NSAIDs  +  antihypertensive drugs are associated with a ‘serious’ ADR (mainly acute renal failure), suggesting that this well‐known DDI is not enough taken into account by prescribers.
Bibliography:istex:E2C751FEA98FFA5F9DEB879369DBCCCFF7C86341
ark:/67375/WNG-W625CWJT-2
ArticleID:FCP12014
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0767-3981
1472-8206
1472-8206
DOI:10.1111/fcp.12014